Eduardo Pérez-Gómez

7PUBLICATIONS
31CO-AUTHORS
Molecular targetsHaematological tumoursAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

|Apr 09, 2026
Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.

Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro

|Jan 06, 2024
Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation.

Isabel Tundidor, Marta Seijo-Vila, Sandra Blasco-Benito

|Jun 28, 2023
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.

María Villa-Morales, Laura Pérez-Gómez, Eduardo Pérez-Gómez

|May 30, 2023
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.

Isabel Tundidor, Marta Seijo-Vila, Sandra Blasco-Benito

|May 13, 2023
Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.

Carlos Costas-Insua, Marta Seijo-Vila, Cristina Blázquez

Pageof 2

Frequent Collaborators

4 joint publications

María Villa-Morales

3 joint publications

Cristina Sánchez

3 joint publications

Manuel Guzmán

2 joint publications

José Fernández-Piqueras